Aspen, Adcock get lion's share of drug tender

Aspen Pharmacare and Adcock Ingram, the biggest pharmaceutical firms listed on the JSE, yesterday welcomed the award of the R2,55-billion oral solids tender, the state's second-biggest medicines contract after HIV/AIDS drugs.

Aspen Pharmacare said it won R634-million of the two-year tender, or 25% of the contract, while Adcock Ingram said it had won R270-million in state business.
The government's industrial policy has designated the pharmaceutical sector as one in which local manufacturers should be given preference, which is intended to stimulate domestic industry and attract foreign investment.

For products that could be obtained from local manufacturers, 70% of the volume required by the state was made available to companies that manufactured the drugs in South Africa.

Adcock Ingram said it had raised its share of the oral solids tender four-fold.

"It is good news for us. We are quite significantly up on where we were before, at about R30-million annually," said Adcock chief executive Jonathan Louw.

Aspen's head of strategic trade Stavros Nicolaou also welcomed the tender award, and said the company's performance was in line with its expectations.

Speaking as a representative of the trade association Pharmaceuticals Made in SA, which counts Aspen among its members, Nicolaou said several key products were being imported, and these represented opportunities for local manufacturers.

"We will be engaging government on how these can be produced locally," he said. These included atorvastatin, used for treating high cholesterol, omeprazole, which counters acid reflux and the anti-seizure drug lamotragine, Nicolaou said.

The tender announcement on the Department of Health's website yesterday, included supply contracts for 461 line items. A further 80 line items have yet to be awarded, say industry sources.

The deputy director-general for health regulation and compliance, Anban Pillay, declined to comment yesterday.

He said officials would issue a press statement at a later stage.

Several small local pharmaceutical companies are involved in the tender including Adminicle and Pharmafrica.

The contract had also, for the first time, split awards among up to four suppliers. Usually they are awarded to one or two suppliers.

South Africa's pharmaceutical manufacturing industry is insignificant by global standards and focused on the production of generic medicines, copies of those originally developed by other firms.

Source: Business Day via I-Net Bridge